VIOLIN Logo
Cov19VaxKB Banner
Search: for Help
Home
Introduction
Statistics
Authorized Vaccines
Phase III Vaccines
Phase II Vaccines
Phase I Vaccines
Preclinical Vaccines
Vaccine Safety
Vaccine Design
Literature Search
News
Data Submission
Data Exchange
Data Download
Tutorial
Links
Documentation
Updates
Acknowledgements
FAQs
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Last Month

From Nov 01, 2024 To Nov 30, 2024 :

SARS-CoV-2 (COVID-19)

  1. Abba Moussa D, Vazquez M, Chable-Bessia C, Roux-Portalez V, Tamagnini E, Pedotti M, Simonelli L, Ngo G, Souchard M, Lyonnais S, Chentouf M, Gros N, Marsile-Medun S, Dinter H, Pugnière M, Martineau P, Varani L, Juan M, Calderon H, Naranjo-Gomez M, Pelegrin M. Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches Emerging microbes & infections 14(1):2432345 2025 [PMID: 39584380]
  2. Sahu M, Praharaj D, Bhadoria AS. Vaccination Strategies for a Liver Transplant Recipient Journal of clinical and experimental hepatology 15(2):102421 2025 [PMID: 39588050]
  3. Cobre AF, Fachi MM, Domingues KZA, Lazo REL, Ferreira LM, Tonin FS, Pontarolo R. Accuracy of COVID-19 diagnostic tests via infrared spectroscopy: A systematic review and meta-analysis Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 327:125337 2025 [PMID: 39481165]
  4. Osman A, Ralston MJ, Povelaitis MC, Mitre M. COVID-19 infection or vaccination and hidradenitis suppurativa: A systematic review JAAD international 18:32-34 2025 [PMID: 39610769]
  5. Braverman G, Barbhaiya M, Nong M, Mandl LA. Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination: A Narrative Review Rheumatic diseases clinics of North America 51(1):75-92 2025 [PMID: 39550108]
  6. Ezeh N, Boadi T, Danila MI, Ramsey-Goldman R, Feldman CH. Interventions to Improve COVID-19 Vaccine Hesitancy Rheumatic diseases clinics of North America 51(1):61-73 2025 [PMID: 39550107]
  7. Ammitzbøll C, Thomsen MK, Erikstrup C, Troldborg A. Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients Rheumatic diseases clinics of North America 51(1):45-59 2025 [PMID: 39550106]
  8. Waghmare A, Hijano DR. SARS-CoV-2 Infection and COVID-19 in Children Rheumatic diseases clinics of North America 51(1):139-156 2025 [PMID: 39550102]
  9. Bertini CD Jr, Khawaja F, Sheshadri A. Coronavirus Disease-2019 in the Immunocompromised Host Rheumatic diseases clinics of North America 51(1):123-138 2025 [PMID: 39550101]
  10. Pozdnyakova V, Weber B, Cheng S, Ebinger JE. Review of Immunologic Manifestations of COVID-19 Infection and Vaccination Rheumatic diseases clinics of North America 51(1):111-121 2025 [PMID: 39550100]
  11. Kohn SO, Jagadish I, McNaughton J, Young KJ. The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases Rheumatic diseases clinics of North America 51(1):1-13 2025 [PMID: 39550099]
  12. Wei L, Yu P, Wang H, Liu J. Adeno-associated viral vectors deliver gene vaccines European journal of medicinal chemistry 281:117010 2025 [PMID: 39488197]
  13. Le MVK, Pourzadi N, Gailer J. Retention behavior of Hg(2+), MeHg(+), thimerosal and phenylmercuric acetate on a C(18) RP-HPLC column Journal of chromatography. A 1739:465546 2025 [PMID: 39608236]
  14. Al-Omoush O, Khalil L, Ramadan A, Tarakhan H, Alzoubi A, Nabil A, Hajali M, Abdelazeem B, Saleh O. Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series Reviews in medical virology 35(1):e70011 2025 [PMID: 39609037]
  15. Ergun T. Urticarial vasculitis Current opinion in rheumatology 37(1):45-50 2025 [PMID: 39600289]
  16. Manca T. "Vaccines protect both you and your newborn:" A discourse analysis of risk and uncertainty in information about vaccination in pregnancy Social science & medicine (1982) 364:117526 2025 [PMID: 39577165]
  17. Sultana R, Stahelin RV. Strengths and limitations of SARS-CoV-2 virus-like particle systems Virology 601:110285 2025 [PMID: 39536645]
  18. Alharbi AM. Unlocking the potential of dried blood spot sampling for SARS-CoV-2 antibody detection: A pathway to efficient pandemic surveillance Diagnostic microbiology and infectious disease 111(1):116581 2025 [PMID: 39532030]
  19. Donadio V, Incensi A, Furia A, Parisini S, Colaci F, Giannoccaro MP, Morelli L, Ricciardiello F, Di Stasi V, De Maria A, Rizzo G, Liguori R. Small fiber neuropathy associated with COVID-19 infection and vaccination: A prospective case-control study European journal of neurology 32(1):e16538 2025 [PMID: 39526678]
  20. Tyagi S, Tyagi N, Singh A, Gautam A, Singh A, Jindal S, Singh RP, Chaturvedi R, Kushwaha HR. Linking COVID-19 and cancer: Underlying mechanism Biochimica et biophysica acta. Molecular basis of disease 1871(1):167563 2025 [PMID: 39510388]
  21. Willis DE, Li J, Selig JP, Moore R, Green A, Purvis RS, Lovelady N, Macechko MD, McElfish PA. Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates Patient education and counseling 130:108481 2025 [PMID: 39504805]
  22. Le Breton A, Touzet H, Fressard L, Chamboredon P, Peretti-Watel P, Ward J, Verger P. Dissatisfaction with working conditions associated with lower vaccine confidence, commitment and behaviors among nurses: A large scale cross-sectional survey in France International journal of nursing studies 161:104935 2025 [PMID: 39489079]
  23. Cheng CY, Su YS, Chen CL, Chang M, Huang SW, Huang PN, Shih SR, Hsu YS, Chiu CH. Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study Human vaccines & immunotherapeutics 20(1):2432105 2024 [PMID: 39611611]
  24. Kim Y, Jang EJ, Hwang JY, Lee KM, Xayaheuang S, Choi ST, Park H. Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2 Human vaccines & immunotherapeutics 20(1):2428516 2024 [PMID: 39610025]
  25. Buaboonnam J, Rungmaitree S, Piyaphanee N, Charuvanij S, Pitisuttithum O, Copeland K, Pheerapanyawaranun C, Jansarikit L, Niyomnaitham S, Chokephaibulkit K. Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study Human vaccines & immunotherapeutics 20(1):2428011 2024 [PMID: 39575846]
  26. Lee A, Davido B, Beck E, Demont C, Joshi K, Kohli M, Maschio M, Uhart M, El Mouaddin N. Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France Human vaccines & immunotherapeutics 20(1):2423474 2024 [PMID: 39540209]
  27. Elhassan Taha MM, Abdelwahab SI, Moni SS, Farasani A, Aljahdali IA, Oraibi B, Alfaifi HA, Alzahrani AH, Ali Jerah A. Nano-enhanced immunity: A bibliometric analysis of nanoparticles in vaccine adjuvant research Human vaccines & immunotherapeutics 20(1):2427464 2024 [PMID: 39539151]
  28. Zhang SS, Shi W, Du J, Zhang WX, Yuan M, Zhou Y, Wang L, Zhao T, Ma QY, Zhang S, Yang H, Zhang X, Wang M, Huang N, Zeng J, Liu Y, Zhang Y, Cui F, Lu QB. Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China Human vaccines & immunotherapeutics 20(1):2428017 2024 [PMID: 39539085]
  29. Yu MKL, Chan SHS, Leung D, Cheng S, Tsang LCH, Kwan TC, Zhang K, Wang X, Tu W, Peiris M, Lau YL, Rosa Duque JS. Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients Human vaccines & immunotherapeutics 20(1):2424615 2024 [PMID: 39539036]
  30. Krishna S, Polonijo AN. Perceived barriers and facilitators to HPV vaccination: Insights from focus groups with unvaccinated mid-adults in a U.S. medically underserved area Human vaccines & immunotherapeutics 20(1):2422681 2024 [PMID: 39539025]
  31. Guillaume AS, Ndwandwe D, Nyalundja AD, Bugeme PM, Ntaboba AB, Hatu'm VU, Tamuzi JL, Iwu-Jaja C, Shindano TA, Wiysonge CS, Katoto PDMC. Caregivers' hesitancy and outright refusal toward children's COVID-19 vaccination in the Democratic Republic of Congo: A community-based cross-sectional study Human vaccines & immunotherapeutics 20(1):2422686 2024 [PMID: 39535129]
  32. Chen C, Tang T, Chen Z, Chen L, Cheng J, Li F, Sun J, Zhao J, Wang Y, Yan Q, Zhao J, Zhu A. Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines Human vaccines & immunotherapeutics 20(1):2423466 2024 [PMID: 39535117]
  33. Wu JS, Huang KK. Measuring influencing factors affecting mortality rates during the COVID-19 pandemic Global health action 17(1):2428067 2024 [PMID: 39530400]
  34. Alshagrawi S. Impact of COVID-19 pandemic on influenza vaccination rate among health care workers Human vaccines & immunotherapeutics 20(1):2426284 2024 [PMID: 39523588]
  35. Karras J, Harrison M, Petrakis D, Gore E, Seale H. "I'd just love to hear what the community has to say": Exploring the potential of community-driven vaccine messaging amongst ethnic minority communities Human vaccines & immunotherapeutics 20(1):2423469 2024 [PMID: 39501658]
  36. Roy A, Paul I, Paul T, Dihidar A, Ray S. Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses Biochemical and biophysical research communications 739:150948 2024 [PMID: 39531907]
  37. Fricke C, Ulrich L, Kochmann J, Gergen J, Kovacikova K, Roth N, Beer J, Schnepf D, Mettenleiter TC, Rauch S, Petsch B, Hoffmann D, Beer M, Corleis B, Dorhoi A. mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice Molecular therapy. Nucleic acids 35(4):102360 2024 [PMID: 39524696]
  38. Gijze S, Wasynczuk A, van Leeuwen L, Grobben M, van Gils MJ, Nouta J, Wang W, Dalm VA, Jolink H, Wuhrer M, Falck D. Simultaneous Protein Quantitation and Glycosylation Profiling of Antigen-Specific Immunoglobulin G1 in Large Clinical Studies Journal of proteome research 23(12):5600-5605 2024 [PMID: 39537390]
  39. Degnan DJ, Strauch CW, Obiri MY, VonKaenel ED, Kim GS, Kershaw JD, Novelli DL, Pazdernik KT, Bramer LM. Protein-Protein Interaction Networks Derived from Classical and Machine Learning-Based Natural Language Processing Tools Journal of proteome research 23(12):5395-5404 2024 [PMID: 39526844]
  40. Laghlali G, Wiest MJ, Karadag D, Warang P, O'Konek JJ, Chang LA, Park SC, Yan V, Farazuddin M, Janczak KW, García-Sastre A, Baker JR Jr, Wong PT, Schotsaert M. Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant Molecular therapy : the journal of the American Society of Gene Therapy 32(12):4448-4466 2024 [PMID: 39489918]
  41. Shoham S, Focosi D, Franchini M, Atamna A. Novel approaches for preventing COVID-19 infection in immunocompromised patients with hematologic malignancies Expert review of hematology :1-8 2024 [PMID: 39610334]
  42. Abt ER, Lam AK, Noguchi M, Rashid K, McLaughlin J, Teng PL, Tran W, Cheng D, Nesterenko PA, Mao Z, Creech AL, Burton Sojo G, Jeyachandran AV, Tam YK, Henley JE, Comai L, Pardi N, Arumugaswami V, Witte ON, Radu CG, Wu TT. Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire Proceedings of the National Academy of Sciences of the United States of America 121(49):e2406332121 2024 [PMID: 39589869]
  43. Klein EY, Impalli I, Poleon S, Denoel P, Cipriano M, Van Boeckel TP, Pecetta S, Bloom DE, Nandi A. Global trends in antibiotic consumption during 2016-2023 and future projections through 2030 Proceedings of the National Academy of Sciences of the United States of America 121(49):e2411919121 2024 [PMID: 39556760]
  44. Kafle U, Truong HQ, Nguyen CTG, Meng F. Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects Molecular pharmaceutics 21(12):5944-5959 2024 [PMID: 39529245]
  45. Pelaccio K, Mo M, Olmsted A, DeJager K. Impact of a human papillomavirus vaccination clinical program in a commercially insured population Journal of managed care & specialty pharmacy 30(12):1405-1413 2024 [PMID: 39612253]
  46. Aburisheh KH, Enabi HMK, Alodah NA, Alotary BH, Algheryafi LA, Almairi AM, Aldhewaila AA. New Onset of Type 1 Diabetes Mellitus Post-COVID-19 Vaccine Journal of medical cases 15(12):367-370 2024 [PMID: 39610907]
  47. Lachiewicz AM, Shah M, Der T, Cyr D, Al-Khalidi HR, Lindsell C, Iyer V, Khan A, Panettieri R, Rauseo AM, Maillo M, Schmid A, Jagpal S, Powderly WG, Bozzette SA. Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis CHEST critical care 2(4) 2024 [PMID: 39610848]
  48. Wang J, Ni S, Chen Q, Wang C, Liu H, Huang L, Nasir MW, Wang W, Zhang X, Wu J, Liu Z, Wu J, Zhang L, Gao Y. Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS-CoV-2 Vaccine and the Resultant Neutralization Activity Journal of medical virology 96(12):e70073 2024 [PMID: 39610345]
  49. Jia T, Wang F, Chen Y, Liao G, Xu Q, Chen J, Wu J, Li N, Wang L, Yuan L, Wang D, Xie Q, Luo C, Luo H, Wang Y, Chen Y, Shu Y. Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination The Journal of infection 89(6):106362 2024 [PMID: 39608577]
  50. Okuyama R. Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines Journal of market access & health policy 12(4):317-325 2024 [PMID: 39588277]
  51. Hinderstein S, Aragona E, Loyal J. Parent Perspectives on Nirsevimab for Their Newborn Pediatrics 154(6) 2024 [PMID: 39587878]
  52. van Vliet E, Lipovec NČ, van der Goot M, Abtahi S, Ribeiro-Vaz I, Poplavska E, Dermiki-Gkana F, Oikonomou C, Deligianni E, Kontogiorgis C, Silva AM, Ferreira PBS, Kos M, Almarsdóttir AB, Jacobsen R, Buhl C, de Bruijn A, Hegger I, Alves TL. Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals Pharmacoepidemiology and drug safety 33(12):e70057 2024 [PMID: 39586738]
  53. Kajova M, Khawaja T, Levonen I, Pietilä JP, Virtanen J, Pakkanen SH, Välimaa H, Nousiainen A, Hepojoki J, Sironen T, Vierikko A, Ihalainen J, Vapalahti O, Kantele A. Convalescent plasma therapy for COVID-19 - Donor selection strategies and establishment of a plasma bank New microbes and new infections 62:101525 2024 [PMID: 39584055]
  54. Perez-Campuzano V, Rautou PE, Marjot T, Praktiknjo M, Alvarado-Tapias E, Turco L, Ibáñez-Samaniego L, González-Alayón C, Puente Á, Llop E, Simón-Talero M, Álvarez-Navascués C, Reiberger T, Verhelst X, Tellez L, Bergmann JB, Orts L, Grassi G, Baiges A, Audrey P, Trebicka J, Villanueva C, Morelli MC, Murray S, Meacham G, Luetgehetmann M, Schulze Zur Wiesch J, García-Pagán JC, Barnes E, Plessier A, Hernández-Gea V. Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study JHEP reports : innovation in hepatology 6(12):101191 2024 [PMID: 39583091]
  55. Lu J, Vulesevic B, Burchell AN, Singer J, Needham J, Yang Y, Qian H, Chambers C, Samji H, Colmegna I, Del Canto S, Godin GH, Habanyama M, Hui SSC, Kroch A, Mandarino E, Margolese S, Martin C, Owino M, Lau E, Mohammadi T, Zhang W, Pelaez S, Kovacs C, Benko E, Cooper CL, Anis AH, Costiniuk CT. Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada Vaccine: X 21:100566 2024 [PMID: 39582795]
  56. Rover MM, Scolari FL, Trott G, da Silva MMD, de Souza D, da Rosa Minho Dos Santos R, De Carli Schardosim RF, de Souza Roldão E, Pozza Estivalete G, Rech GS, Mocellin D, de Souza JMB, Miozzo AP, Itaqui CR, da Silva GN, de Mesquita Neto J, Freitas HJM, Dos Santos CVP, da Silveira AS, D'Ávila CM, Soares CM, Vítor Gozzi J, Dos Santos IF, Carvalho SM, Irineu VM, Silvestre OM, do Carmo Marinho Borges K, de Menezes Neves PDM, Junior FAM, Schleder JC, Dos Santos TP, Lanna Figueiredo E, da Fonseca BAL, Zimmermann SL, Pompilho MA, Facchi LM, Gebara OCE, Marcolino MS, Antonio ACP, Schvartzman PR, Barreto BB, Robinson CC, Falavigna M, Nasi LA, Polanczyk CA, Biolo A, Rosa RG. Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study Vaccine: X 21:100579 2024 [PMID: 39582794]
  57. Amin MR, Anwar KN, Ashraf MJ, Ghassemi M, Novak RM. Preventing human influenza and coronaviral mono or coinfection by blocking virus-induced sialylation Antiviral research 232:106041 2024 [PMID: 39581502]
  58. Chow NKN, Tsang CYW, Chan YH, Telaga SA, Ng LYA, Chung CM, Yip YM, Cheung PP. The effect of pre-COVID and post-COVID vaccination on long COVID: A systematic review and meta-analysis The Journal of infection 89(6):106358 2024 [PMID: 39580033]
  59. Dhanasekaran P, Karasu BT, Mak A. Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review Rheumatology international 44(12):2757-2794 2024 [PMID: 39576327]
  60. Sasaki J, Sato A, Sasaki M, Okabe I, Kodama K, Otsuguro S, Yasuda K, Kojima H, Orba Y, Sawa H, Maenaka K, Yanagi Y, Hashiguchi T. X-206 exhibits broad-spectrum anti-β-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates Antiviral research 232:106039 2024 [PMID: 39571911]
  61. Jermsutjarit P, Venkateswaran D, Indrawattana N, Na Plord J, Tantituvanont A, Nilubol D. The development of a lateral flow immunochromatographic test strip for measurement of specific IgA and IgG antibodies level against porcine epidemic diarrhea virus in pig milk The veterinary quarterly 44(1):1-15 2024 [PMID: 39568374]
  62. D'Onofrio V, Sékaly RP. The immune-endocrine interplay in sex differential responses to viral infection and COVID-19 Trends in immunology 45(12):943-958 2024 [PMID: 39562265]
  63. Begovac J. First real-life data on COVID-19 vaccine effectiveness against hospitalisation and severe disease from the eastern part of the WHO European Region The Lancet regional health. Europe 47:101130 2024 [PMID: 39559480]
  64. Khanna AS, Monnig MA, Clark SE, Monti PM. Social network characteristics of COVID-19 vaccination and preventive health behaviors: Cross-sectional findings from the US northeast during the early COVID-19 pandemic Vaccine: X 21:100577 2024 [PMID: 39555244]
  65. Hyun Lim S, Hersi M, Krishnan R, Montroy J, Rook B, Farrah K, Chung YE, Stevens A, Zafack J, Wong E, Forbes N, Killikelly A, Young K, Tunis M. COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literature Vaccine: X 21:100575 2024 [PMID: 39555243]
  66. White TM, Wyka K, Rabin K, El-Mohandes A. Trust in the science behind COVID-19 vaccines as a driver of vaccine acceptance in the United States, 2021-2023 Vaccine: X 21:100576 2024 [PMID: 39555242]
  67. Lecouturier J, Kelly MP, Sniehotta FF. Reaching national Covid-19 vaccination targets whilst decreasing inequalities in vaccine uptake: Public health teams' challenges in supporting disadvantaged populations Public health in practice (Oxford, England) 8:100551 2024 [PMID: 39554618]
  68. Abe S, Wannigama DL, Suzuki Y, Akaneya D, Igarashi J, Suto M, Moriya K, Ishizawa D, Okuma Y, Hongsing P, Hurst C, Saethang T, Higgins PG, Stick SM, Kicic A. Real world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series New microbes and new infections 62:101522 2024 [PMID: 39552926]
  69. McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall HS, Estcourt MJ, Wadia U, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Cain N, Brizuela R, Faust SN, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond PC. The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old The Journal of infection 89(6):106346 2024 [PMID: 39550007]
  70. Welch SR, Bilello JP, Carter K, Delang L, Dirr L, Durantel D, Feng JY, Gowen BB, Herrero LJ, Janeba Z, Kleymann G, Lee AA, Meier C, Moffat J, Schang LM, Schiffer JT, Seley-Radtke KL, Sheahan TP, Spengler JR. Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral Research Antiviral research 232:106037 2024 [PMID: 39542140]
  71. Xiao Y, Isaacs SN. Poxvirus vaccines: the evolution of an 18th-century vaccine to the 21st century Trends in pharmacological sciences 45(12):1086-1088 2024 [PMID: 39537527]
  72. Chen Z, Xiao L, Zhou J, Wang W, Guo R, Li J, Li B. A new S1 subunit truncation vaccine induces effective protection against porcine deltacoronavirus in suckling piglets Veterinary microbiology 299:110303 2024 [PMID: 39536688]
  73. Feurer D, Riffe T, Kniffka MS, Acosta E, Armstrong B, Mistry M, Lowe R, Royé D, Hashizume M, Madaniyazi L, Ng CFS, Tobias A, Íñiguez C, Vicedo-Cabrera AM, Ragettli MS, Lavigne E, Correa PM, Ortega NV, Kyselý J, Urban A, Orru H, Indermitte E, Maasikmets M, Dallavalle M, Schneider A, Honda Y, Alahmad B, Zanobetti A, Schwartz J, Carrasco G, Holobâca IH, Kim H, Lee W, Bell ML, Scovronick N, Acquaotta F, Coélho MSZS, Diaz MH, Arellano EEF, Michelozzi P, Stafoggia M, de'Donato F, Rao S, Di Ruscio F, Seposo X, Guo Y, Tong S, Masselot P, Gasparrini A, Sera F. Meteorological factors, population immunity, and COVID-19 incidence: A global multi-city analysis Environmental epidemiology (Philadelphia, Pa.) 8(6):e338 2024 [PMID: 39534387]
  74. Pinte L, Dima A, Draghici A, Caraghiulea M, Zamfir-Gradinaru IA, Baicus C. Autoimmunity, a relevant exclusion criterion in the development of mRNA-based compounds: A systematic review of clinical trials registries Autoimmunity reviews 23(12):103670 2024 [PMID: 39527992]
  75. Wu K, Xu F, Dai Y, Jin S, Zheng A, Zhang N, Xu Y. Characterization of mRNA-LNP structural features and mechanisms for enhanced mRNA vaccine immunogenicity Journal of controlled release : official journal of the Controlled Release Society 376:1288-1299 2024 [PMID: 39522562]
  76. Arora P, Happle C, Kempf A, Nehlmeier I, Stankov MV, Dopfer-Jablonka A, Behrens GMN, Pöhlmann S, Hoffmann M. Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC The Lancet. Infectious diseases 24(12):e732-e733 2024 [PMID: 39522531]
  77. Kaku Y, Okumura K, Kawakubo S, Uriu K, Chen L, Kosugi Y, Uwamino Y, Begum MM, Leong S, Ikeda T, Sadamasu K, Asakura H, Nagashima M, Yoshimura K, Ito J, Sato K. Virological characteristics of the SARS-CoV-2 XEC variant The Lancet. Infectious diseases 24(12):e736 2024 [PMID: 39521009]
  78. Costa-Font J, Docrat F. Discrimination backfires? Minority ethnic disparities in vaccine hesitancy Economics and human biology 55:101441 2024 [PMID: 39520967]
  79. Dulfer EA, Föhse K, Taks EJM, Moorlag SJCFM, Koekenbier EL, van de Maat JS, Ten Oever J, Hoogerwerf JJ, van Werkhoven CH, Bonten MJM, van Hylckama Vlieg A, Rosendaal FR, Netea MG. The effect of BCG vaccination in the elderly on infectious and non-infectious immune-mediated diseases The Journal of infection 89(6):106344 2024 [PMID: 39515666]
  80. Griffiths M, Hatabah D, Sullivan P, Mantus G, Sanchez T, Zlotorzynska M, Heilman S, Camacho-Gonzalez A, Leake D, Korman R, Le M, Suthar M, Wrammert J, Vos MB, Morris CR. Corrigendum to "Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study" [Internation Journal of Infectious Diseases, volume 144 (2024) 107064] International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 149:107278 2024 [PMID: 39515078]
  81. De Gaetano A, Barrat A, Paolotti D. Modeling the interplay between disease spread, behaviors, and disease perception with a data-driven approach Mathematical biosciences 378:109337 2024 [PMID: 39510244]
  82. Shen S, Findlow J, Peyrani P. Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review Infectious diseases and therapy 13(12):2489-2507 2024 [PMID: 39509011]
  83. Guruvaiah Sridhara N, Guruvaiah Sridhara N, Ponnatapura J. Emerging complications in the era of COVID-19 vaccination: role of radiologists and imaging Clinical imaging 116:110338 2024 [PMID: 39504910]
  84. Dey M, Doskaliuk B, Parodis I, Lindblom J, Wincup C, Joshi M, Dey D, Katchamart W, Kadam E, Sen P, Shinjo SK, Nune A, Goo PA, Ziade N, Chen YM, Traboco LS, Gutiérrez CET, Vaidya B, Agarwal V, Gupta L, Nikiphorou E. COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey Rheumatology international 44(12):2853-2861 2024 [PMID: 39503760]
  85. Pignolo RJ, King KS, Wi CI, Ryu E, Takahashi PY, Yao JD, Binnicker MJ, Dixon RE, Natoli TL, Juhn YJ. Characteristics of an Older Adult Population Without COVID-19 Infection in a Southeast Minnesota Community Mayo Clinic proceedings 99(12):1921-1932 2024 [PMID: 39503643]
  86. Shen XL, Jiang YH, Li SJ, Xie XY, Cheng Y, Wu L, Shen J, Chen W, Liu JR. Clinical features and predictive nomogram for fatigue sequelae in non-severe patients infected with SARS-CoV-2 Omicron variant in Shanghai, China Brain, behavior, & immunity - health 42:100889 2024 [PMID: 39498382]
  87. Wang H, Wei Y, Lin G, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study Emerging microbes & infections 13(1):2421397 2024 [PMID: 39497519]
  88. Olson SM, Dawood FS, Grohskopf LA, Ellington S. Preventing Influenza Virus Infection and Severe Influenza Among Pregnant People and Infants Journal of women's health (2002) 33(12):1591-1598 2024 [PMID: 39491270]
  89. Wang H, Zhou Y, Chu L, Chen K, Fu C. Guardian-driven influenza vaccination intentions for children post-COVID-19 in the 2024-2025 season: The positive spillover effects The Journal of infection 89(6):106333 2024 [PMID: 39490812]
  90. Dono F, Dasara M, Evangelista G, Sensi S. Unraveling the connection: Insights into SARS-CoV-2 vaccines and status epilepticus Seizure 123:49-50 2024 [PMID: 39490005]
  91. Xu X, Sun J, Zheng H, Du X, Wang Y, Cheng J, Liu Y, Ying J, Zhao Y, Wang Z, Yan J, Duan X, Yang Y, Ye Z, Sun D, Song H, Su M. Isolation and characterization of a novel S-gene mutation porcine deltacoronavirus with high pathogenicity from diarrhea piglet in Zhejiang Province, China, 2022 Microbial pathogenesis 197:107095 2024 [PMID: 39486553]
  92. Pagliuca A, Kaul S, Goodyear CS, Lee L. Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies now Infectious diseases (London, England) 56(12):1107-1110 2024 [PMID: 39482903]
  93. Wang N, Fan H, Wang Y, Shu C, Lin Q, Hu P, Wang N, Zhang D. The hybrid immunity defined by weaker immune imprinting of people living with HIV has a stronger neutralizing response against Omicron variants. A suggested explanation for fewer symptoms in people living with HIV after SARS-CoV-2 variants breakthrough infection Life sciences 358:123197 2024 [PMID: 39481835]
  94. Chupak AL, Rudisill C, Harrison S, Linvill K, Costa-Font J, Hung P, Li X. Impact of perceived neighborhood social cohesion on vaccination intentions in the post-pandemic era Preventive medicine 189:108158 2024 [PMID: 39481611]
  95. Mori T, Kitano T, Kitagawa D, Murata M, Onishi M, Hachisuka S, Okubo T, Yamamoto N, Nishikawa H, Onaka M, Suzuki R, Sekine M, Suzuki S, Nakamura F, Yoshida S. Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era Journal of infection and public health 17(12):102570 2024 [PMID: 39481292]
  96. Hansen KT, Povlsen FK, Bech BH, Hansen SN, Rask CU, Fink P, Nielsen H, Dantoft TM, Thysen SM, Rytter D. Does health anxiety and vaccine concern predict self-reported adverse events following COVID-19 vaccination?-A Danish national cohort study Public health 237:299-306 2024 [PMID: 39481186]
  97. Amrouche T, Lammi S, Drider D. Probiotics and Prebiotics Intervention in Respiratory and Digestive Infections Linked to Covid-19 Probiotics and antimicrobial proteins 2024 [PMID: 39614066]
  98. Malek E, Fallah Mehrabadi MH, Es-Haghi A, Nofeli M, Mokaram AR, Moradi MH, Razaz SH, Solaymani-Dodaran M, Kalantari S, Sadeghi F, Mokhberalsafa L, Banihashemi SR. Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety Heliyon 10(22):e40124 2024 [PMID: 39584086]
  99. Mukherjee R, Eggesbø LM, Wolf AS, Kjønstad IF, Solum G, Ravussin A, Bhandari S, Robertson AH, Magnus P, Trogstad L, Kristoffersen AB, Nygaard UC, Mjaaland S. Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly NPJ vaccines 9(1):238 2024 [PMID: 39613759]
  100. Kang HM, Kim HJ, Jung J, Ahn JY, Song KH, Baek JY, Choi JY, Lee YJ, Jeong H, Kim SH, Park S, Jang HM, Rhie GE, Kim ES, Choi JY, Kim SH, Kang ES, Peck KR, Jeong HW, Ko JH. Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study The Journal of infectious diseases 2024 [PMID: 39612911]

See more by clicking HERE

Coronavirus

  1. Abba Moussa D, Vazquez M, Chable-Bessia C, Roux-Portalez V, Tamagnini E, Pedotti M, Simonelli L, Ngo G, Souchard M, Lyonnais S, Chentouf M, Gros N, Marsile-Medun S, Dinter H, Pugnière M, Martineau P, Varani L, Juan M, Calderon H, Naranjo-Gomez M, Pelegrin M. Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches Emerging microbes & infections 14(1):2432345 2025 [PMID: 39584380]
  2. Cobre AF, Fachi MM, Domingues KZA, Lazo REL, Ferreira LM, Tonin FS, Pontarolo R. Accuracy of COVID-19 diagnostic tests via infrared spectroscopy: A systematic review and meta-analysis Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 327:125337 2025 [PMID: 39481165]
  3. Braverman G, Barbhaiya M, Nong M, Mandl LA. Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination: A Narrative Review Rheumatic diseases clinics of North America 51(1):75-92 2025 [PMID: 39550108]
  4. Ezeh N, Boadi T, Danila MI, Ramsey-Goldman R, Feldman CH. Interventions to Improve COVID-19 Vaccine Hesitancy Rheumatic diseases clinics of North America 51(1):61-73 2025 [PMID: 39550107]
  5. Ammitzbøll C, Thomsen MK, Erikstrup C, Troldborg A. Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients Rheumatic diseases clinics of North America 51(1):45-59 2025 [PMID: 39550106]
  6. Waghmare A, Hijano DR. SARS-CoV-2 Infection and COVID-19 in Children Rheumatic diseases clinics of North America 51(1):139-156 2025 [PMID: 39550102]
  7. Bertini CD Jr, Khawaja F, Sheshadri A. Coronavirus Disease-2019 in the Immunocompromised Host Rheumatic diseases clinics of North America 51(1):123-138 2025 [PMID: 39550101]
  8. Pozdnyakova V, Weber B, Cheng S, Ebinger JE. Review of Immunologic Manifestations of COVID-19 Infection and Vaccination Rheumatic diseases clinics of North America 51(1):111-121 2025 [PMID: 39550100]
  9. Kohn SO, Jagadish I, McNaughton J, Young KJ. The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases Rheumatic diseases clinics of North America 51(1):1-13 2025 [PMID: 39550099]
  10. Ergun T. Urticarial vasculitis Current opinion in rheumatology 37(1):45-50 2025 [PMID: 39600289]
  11. Sultana R, Stahelin RV. Strengths and limitations of SARS-CoV-2 virus-like particle systems Virology 601:110285 2025 [PMID: 39536645]
  12. Alharbi AM. Unlocking the potential of dried blood spot sampling for SARS-CoV-2 antibody detection: A pathway to efficient pandemic surveillance Diagnostic microbiology and infectious disease 111(1):116581 2025 [PMID: 39532030]
  13. Tyagi S, Tyagi N, Singh A, Gautam A, Singh A, Jindal S, Singh RP, Chaturvedi R, Kushwaha HR. Linking COVID-19 and cancer: Underlying mechanism Biochimica et biophysica acta. Molecular basis of disease 1871(1):167563 2025 [PMID: 39510388]
  14. Willis DE, Li J, Selig JP, Moore R, Green A, Purvis RS, Lovelady N, Macechko MD, McElfish PA. Healthcare provider recommendations for COVID-19 vaccination: Prevalence, disparities, and correlates Patient education and counseling 130:108481 2025 [PMID: 39504805]
  15. Cheng CY, Su YS, Chen CL, Chang M, Huang SW, Huang PN, Shih SR, Hsu YS, Chiu CH. Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study Human vaccines & immunotherapeutics 20(1):2432105 2024 [PMID: 39611611]
  16. Kim Y, Jang EJ, Hwang JY, Lee KM, Xayaheuang S, Choi ST, Park H. Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2 Human vaccines & immunotherapeutics 20(1):2428516 2024 [PMID: 39610025]
  17. Buaboonnam J, Rungmaitree S, Piyaphanee N, Charuvanij S, Pitisuttithum O, Copeland K, Pheerapanyawaranun C, Jansarikit L, Niyomnaitham S, Chokephaibulkit K. Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study Human vaccines & immunotherapeutics 20(1):2428011 2024 [PMID: 39575846]
  18. Lee A, Davido B, Beck E, Demont C, Joshi K, Kohli M, Maschio M, Uhart M, El Mouaddin N. Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France Human vaccines & immunotherapeutics 20(1):2423474 2024 [PMID: 39540209]
  19. Zhang SS, Shi W, Du J, Zhang WX, Yuan M, Zhou Y, Wang L, Zhao T, Ma QY, Zhang S, Yang H, Zhang X, Wang M, Huang N, Zeng J, Liu Y, Zhang Y, Cui F, Lu QB. Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China Human vaccines & immunotherapeutics 20(1):2428017 2024 [PMID: 39539085]
  20. Yu MKL, Chan SHS, Leung D, Cheng S, Tsang LCH, Kwan TC, Zhang K, Wang X, Tu W, Peiris M, Lau YL, Rosa Duque JS. Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients Human vaccines & immunotherapeutics 20(1):2424615 2024 [PMID: 39539036]
  21. Guillaume AS, Ndwandwe D, Nyalundja AD, Bugeme PM, Ntaboba AB, Hatu'm VU, Tamuzi JL, Iwu-Jaja C, Shindano TA, Wiysonge CS, Katoto PDMC. Caregivers' hesitancy and outright refusal toward children's COVID-19 vaccination in the Democratic Republic of Congo: A community-based cross-sectional study Human vaccines & immunotherapeutics 20(1):2422686 2024 [PMID: 39535129]
  22. Chen C, Tang T, Chen Z, Chen L, Cheng J, Li F, Sun J, Zhao J, Wang Y, Yan Q, Zhao J, Zhu A. Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines Human vaccines & immunotherapeutics 20(1):2423466 2024 [PMID: 39535117]
  23. Wu JS, Huang KK. Measuring influencing factors affecting mortality rates during the COVID-19 pandemic Global health action 17(1):2428067 2024 [PMID: 39530400]
  24. Alshagrawi S. Impact of COVID-19 pandemic on influenza vaccination rate among health care workers Human vaccines & immunotherapeutics 20(1):2426284 2024 [PMID: 39523588]
  25. Roy A, Paul I, Paul T, Dihidar A, Ray S. Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses Biochemical and biophysical research communications 739:150948 2024 [PMID: 39531907]
  26. Fricke C, Ulrich L, Kochmann J, Gergen J, Kovacikova K, Roth N, Beer J, Schnepf D, Mettenleiter TC, Rauch S, Petsch B, Hoffmann D, Beer M, Corleis B, Dorhoi A. mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice Molecular therapy. Nucleic acids 35(4):102360 2024 [PMID: 39524696]
  27. Gijze S, Wasynczuk A, van Leeuwen L, Grobben M, van Gils MJ, Nouta J, Wang W, Dalm VA, Jolink H, Wuhrer M, Falck D. Simultaneous Protein Quantitation and Glycosylation Profiling of Antigen-Specific Immunoglobulin G1 in Large Clinical Studies Journal of proteome research 23(12):5600-5605 2024 [PMID: 39537390]
  28. Degnan DJ, Strauch CW, Obiri MY, VonKaenel ED, Kim GS, Kershaw JD, Novelli DL, Pazdernik KT, Bramer LM. Protein-Protein Interaction Networks Derived from Classical and Machine Learning-Based Natural Language Processing Tools Journal of proteome research 23(12):5395-5404 2024 [PMID: 39526844]
  29. Laghlali G, Wiest MJ, Karadag D, Warang P, O'Konek JJ, Chang LA, Park SC, Yan V, Farazuddin M, Janczak KW, García-Sastre A, Baker JR Jr, Wong PT, Schotsaert M. Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant Molecular therapy : the journal of the American Society of Gene Therapy 32(12):4448-4466 2024 [PMID: 39489918]
  30. Abt ER, Lam AK, Noguchi M, Rashid K, McLaughlin J, Teng PL, Tran W, Cheng D, Nesterenko PA, Mao Z, Creech AL, Burton Sojo G, Jeyachandran AV, Tam YK, Henley JE, Comai L, Pardi N, Arumugaswami V, Witte ON, Radu CG, Wu TT. Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire Proceedings of the National Academy of Sciences of the United States of America 121(49):e2406332121 2024 [PMID: 39589869]
  31. Klein EY, Impalli I, Poleon S, Denoel P, Cipriano M, Van Boeckel TP, Pecetta S, Bloom DE, Nandi A. Global trends in antibiotic consumption during 2016-2023 and future projections through 2030 Proceedings of the National Academy of Sciences of the United States of America 121(49):e2411919121 2024 [PMID: 39556760]
  32. Kafle U, Truong HQ, Nguyen CTG, Meng F. Development of Thermally Stable mRNA-LNP Delivery Systems: Current Progress and Future Prospects Molecular pharmaceutics 21(12):5944-5959 2024 [PMID: 39529245]
  33. Aburisheh KH, Enabi HMK, Alodah NA, Alotary BH, Algheryafi LA, Almairi AM, Aldhewaila AA. New Onset of Type 1 Diabetes Mellitus Post-COVID-19 Vaccine Journal of medical cases 15(12):367-370 2024 [PMID: 39610907]
  34. Lachiewicz AM, Shah M, Der T, Cyr D, Al-Khalidi HR, Lindsell C, Iyer V, Khan A, Panettieri R, Rauseo AM, Maillo M, Schmid A, Jagpal S, Powderly WG, Bozzette SA. Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis CHEST critical care 2(4) 2024 [PMID: 39610848]
  35. Wang J, Ni S, Chen Q, Wang C, Liu H, Huang L, Nasir MW, Wang W, Zhang X, Wu J, Liu Z, Wu J, Zhang L, Gao Y. Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS-CoV-2 Vaccine and the Resultant Neutralization Activity Journal of medical virology 96(12):e70073 2024 [PMID: 39610345]
  36. Jia T, Wang F, Chen Y, Liao G, Xu Q, Chen J, Wu J, Li N, Wang L, Yuan L, Wang D, Xie Q, Luo C, Luo H, Wang Y, Chen Y, Shu Y. Expanded immune imprinting and neutralization spectrum by hybrid immunization following breakthrough infections with SARS-CoV-2 variants after three-dose vaccination The Journal of infection 89(6):106362 2024 [PMID: 39608577]
  37. Amin MR, Anwar KN, Ashraf MJ, Ghassemi M, Novak RM. Preventing human influenza and coronaviral mono or coinfection by blocking virus-induced sialylation Antiviral research 232:106041 2024 [PMID: 39581502]
  38. Chow NKN, Tsang CYW, Chan YH, Telaga SA, Ng LYA, Chung CM, Yip YM, Cheung PP. The effect of pre-COVID and post-COVID vaccination on long COVID: A systematic review and meta-analysis The Journal of infection 89(6):106358 2024 [PMID: 39580033]
  39. Dhanasekaran P, Karasu BT, Mak A. Safety, efficacy, and immunogenicity of SARS-CoV-2 mRNA vaccination in children and adult patients with rheumatic diseases: a comprehensive literature review Rheumatology international 44(12):2757-2794 2024 [PMID: 39576327]
  40. Sasaki J, Sato A, Sasaki M, Okabe I, Kodama K, Otsuguro S, Yasuda K, Kojima H, Orba Y, Sawa H, Maenaka K, Yanagi Y, Hashiguchi T. X-206 exhibits broad-spectrum anti-β-coronavirus activity, covering SARS-CoV-2 variants and drug-resistant isolates Antiviral research 232:106039 2024 [PMID: 39571911]
  41. Jermsutjarit P, Venkateswaran D, Indrawattana N, Na Plord J, Tantituvanont A, Nilubol D. The development of a lateral flow immunochromatographic test strip for measurement of specific IgA and IgG antibodies level against porcine epidemic diarrhea virus in pig milk The veterinary quarterly 44(1):1-15 2024 [PMID: 39568374]
  42. D'Onofrio V, Sékaly RP. The immune-endocrine interplay in sex differential responses to viral infection and COVID-19 Trends in immunology 45(12):943-958 2024 [PMID: 39562265]
  43. McLeod C, Dymock M, Flanagan KL, Plebanski M, Marshall HS, Estcourt MJ, Wadia U, Tjiam MC, Blyth CC, Subbarao K, Mordant FL, Nicholson S, Cain N, Brizuela R, Faust SN, Thornton RB, Ellis Z, Mckenzie A, Marsh JA, Snelling TL, Richmond PC. The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old The Journal of infection 89(6):106346 2024 [PMID: 39550007]
  44. Chen Z, Xiao L, Zhou J, Wang W, Guo R, Li J, Li B. A new S1 subunit truncation vaccine induces effective protection against porcine deltacoronavirus in suckling piglets Veterinary microbiology 299:110303 2024 [PMID: 39536688]
  45. Pinte L, Dima A, Draghici A, Caraghiulea M, Zamfir-Gradinaru IA, Baicus C. Autoimmunity, a relevant exclusion criterion in the development of mRNA-based compounds: A systematic review of clinical trials registries Autoimmunity reviews 23(12):103670 2024 [PMID: 39527992]
  46. Wu K, Xu F, Dai Y, Jin S, Zheng A, Zhang N, Xu Y. Characterization of mRNA-LNP structural features and mechanisms for enhanced mRNA vaccine immunogenicity Journal of controlled release : official journal of the Controlled Release Society 376:1288-1299 2024 [PMID: 39522562]
  47. Costa-Font J, Docrat F. Discrimination backfires? Minority ethnic disparities in vaccine hesitancy Economics and human biology 55:101441 2024 [PMID: 39520967]
  48. Dulfer EA, Föhse K, Taks EJM, Moorlag SJCFM, Koekenbier EL, van de Maat JS, Ten Oever J, Hoogerwerf JJ, van Werkhoven CH, Bonten MJM, van Hylckama Vlieg A, Rosendaal FR, Netea MG. The effect of BCG vaccination in the elderly on infectious and non-infectious immune-mediated diseases The Journal of infection 89(6):106344 2024 [PMID: 39515666]
  49. De Gaetano A, Barrat A, Paolotti D. Modeling the interplay between disease spread, behaviors, and disease perception with a data-driven approach Mathematical biosciences 378:109337 2024 [PMID: 39510244]
  50. Dey M, Doskaliuk B, Parodis I, Lindblom J, Wincup C, Joshi M, Dey D, Katchamart W, Kadam E, Sen P, Shinjo SK, Nune A, Goo PA, Ziade N, Chen YM, Traboco LS, Gutiérrez CET, Vaidya B, Agarwal V, Gupta L, Nikiphorou E. COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey Rheumatology international 44(12):2853-2861 2024 [PMID: 39503760]
  51. Pignolo RJ, King KS, Wi CI, Ryu E, Takahashi PY, Yao JD, Binnicker MJ, Dixon RE, Natoli TL, Juhn YJ. Characteristics of an Older Adult Population Without COVID-19 Infection in a Southeast Minnesota Community Mayo Clinic proceedings 99(12):1921-1932 2024 [PMID: 39503643]
  52. Shen XL, Jiang YH, Li SJ, Xie XY, Cheng Y, Wu L, Shen J, Chen W, Liu JR. Clinical features and predictive nomogram for fatigue sequelae in non-severe patients infected with SARS-CoV-2 Omicron variant in Shanghai, China Brain, behavior, & immunity - health 42:100889 2024 [PMID: 39498382]
  53. Wang H, Wei Y, Lin G, Boyer C, Jia KM, Hung CT, Jiang X, Li C, Yam CHK, Chow TY, Wang Y, Zhao S, Guo Z, Li K, Yang A, Mok CKP, Hui DSC, Chong KC, Yeoh EK. COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study Emerging microbes & infections 13(1):2421397 2024 [PMID: 39497519]
  54. Xu X, Sun J, Zheng H, Du X, Wang Y, Cheng J, Liu Y, Ying J, Zhao Y, Wang Z, Yan J, Duan X, Yang Y, Ye Z, Sun D, Song H, Su M. Isolation and characterization of a novel S-gene mutation porcine deltacoronavirus with high pathogenicity from diarrhea piglet in Zhejiang Province, China, 2022 Microbial pathogenesis 197:107095 2024 [PMID: 39486553]
  55. Pagliuca A, Kaul S, Goodyear CS, Lee L. Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies now Infectious diseases (London, England) 56(12):1107-1110 2024 [PMID: 39482903]
  56. Wang N, Fan H, Wang Y, Shu C, Lin Q, Hu P, Wang N, Zhang D. The hybrid immunity defined by weaker immune imprinting of people living with HIV has a stronger neutralizing response against Omicron variants. A suggested explanation for fewer symptoms in people living with HIV after SARS-CoV-2 variants breakthrough infection Life sciences 358:123197 2024 [PMID: 39481835]
  57. Chupak AL, Rudisill C, Harrison S, Linvill K, Costa-Font J, Hung P, Li X. Impact of perceived neighborhood social cohesion on vaccination intentions in the post-pandemic era Preventive medicine 189:108158 2024 [PMID: 39481611]
  58. Mori T, Kitano T, Kitagawa D, Murata M, Onishi M, Hachisuka S, Okubo T, Yamamoto N, Nishikawa H, Onaka M, Suzuki R, Sekine M, Suzuki S, Nakamura F, Yoshida S. Risk of admission requirement among children with respiratory infection in the post-COVID-19 pandemic era Journal of infection and public health 17(12):102570 2024 [PMID: 39481292]
  59. Amrouche T, Lammi S, Drider D. Probiotics and Prebiotics Intervention in Respiratory and Digestive Infections Linked to Covid-19 Probiotics and antimicrobial proteins 2024 [PMID: 39614066]
  60. Kang HM, Kim HJ, Jung J, Ahn JY, Song KH, Baek JY, Choi JY, Lee YJ, Jeong H, Kim SH, Park S, Jang HM, Rhie GE, Kim ES, Choi JY, Kim SH, Kang ES, Peck KR, Jeong HW, Ko JH. Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study The Journal of infectious diseases 2024 [PMID: 39612911]
  61. Cruces-Salguero S, Larrañaga I, Mar J, Matheu A. Electronic health records reveal that COVID-19 impacted health resources and survival of Basque population Aging clinical and experimental research 36(1):228 2024 [PMID: 39612148]
  62. Lobaina Y, Musacchio A, Ai P, Chen R, Suzarte E, Chinea G, Zhang M, Zhou Z, Lan Y, Silva R, Guillén G, Yang K, Li W, Perera Y, Hermida L. Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates Virology journal 21(1):310 2024 [PMID: 39609857]
  63. Xu Z, Wu Y, Bai Y, Chen X, Fu G, Jin B. Identification of tumor-antigen signatures and immune subtypes for mRNA vaccine selection in muscle-invasive bladder cancer Surgery :108926 2024 [PMID: 39613663]
  64. De Silva ST, Ediriweera DS, Wimalasena W, Kariyawasam M, Kosinna G, Bogoda G, Senaratne S, Rathnayake K, Weerarathna I, Premaratna R, Gunasena P. Evaluation of BBIBP-CorV Sinopharm COVID-19 vaccine effectiveness in Sri Lanka: a test-negative case control study BMJ open 14(11):e090341 2024 [PMID: 39613443]
  65. Link EK, Tscherne A, Sutter G, Smith ER, Gurwith M, Chen RT, Volz A. A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector Vaccine 43(Pt 1):126521 2024 [PMID: 39612556]
  66. Kadio K, Blake-Hepburn D, Song MY, Karbasi A, Noad EE, Abdi S, Peer N, Fadel SA, Allin S, Ataullahjan A, Di Ruggiero E. Facilitators and challenges in collaboration between public health units and faith-based organizations to promote COVID-19 vaccine confidence in Ontario International journal for equity in health 23(1):254 2024 [PMID: 39609670]
  67. Becker W, Rebbani K, Duan Z, Valkov E, Bryant S, Ho M, Berzofsky JA, Olkhanud PB. Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice Scientific reports 14(1):29609 2024 [PMID: 39609527]
  68. Wu Y, Li L, Wang K, Zhang Y, Wang J, Feng TT, Li YT, Kong Q. COVID-AMD database for coronavirus-infected animal models with comparative analysis tools Scientific reports 14(1):29567 2024 [PMID: 39609461]
  69. Kovalchik KA, Hamelin DJ, Kubiniok P, Bourdin B, Mostefai F, Poujol R, Paré B, Simpson SM, Sidney J, Bonneil É, Courcelles M, Saini SK, Shahbazy M, Kapoor S, Rajesh V, Weitzen M, Grenier JC, Gharsallaoui B, Maréchal L, Wu Z, Savoie C, Sette A, Thibault P, Sirois I, Smith MA, Decaluwe H, Hussin JG, Lavallée-Adam M, Caron E. Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines Nature communications 15(1):10316 2024 [PMID: 39609459]
  70. Kim SW, Alacevich C, Nicodemo C, Wittenberg R, de Lusignan S, Petrou S. The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey PharmacoEconomics - open 2024 [PMID: 39609339]
  71. Musango L, Mandrosovololona V, Randriatsarafara FM, Ranarison VM, Kirigia JM, Ratsimbasoa CA. The present value of human life losses associated with COVID-19 and likely productivity losses averted through COVID-19 vaccination in Madagascar BMC public health 24(1):3296 2024 [PMID: 39604940]
  72. Matovu JKB, Nuwematsiko R, Aanyu C, Tabwenda L, Okade T, Musoke D, Buregyeya E. COVID-19 vaccination, perceptions about the vaccine and willingness to take the vaccine among unvaccinated individuals at two Ugandan border points of entry BMC public health 24(1):3308 2024 [PMID: 39604916]
  73. Abbasifard M, Kazerooni K, Taghipour Khaje Sharifi G, Bagheri-Hosseinabadi Z, Hajizadeh MR. Influence of blood trace elements on immune responses and adverse symptoms subsequent to Sinopharm COVID-19 vaccination Scientific reports 14(1):29481 2024 [PMID: 39604541]
  74. Matson RP, Comba IY, Silvert E, Niesen MJM, Murugadoss K, Patwardhan D, Suratekar R, Goel EG, Poelaert BJ, Wan KK, Brimacombe KR, Venkatakrishnan AJ, Soundararajan V. A deep learning approach predicting the activity of COVID-19 therapeutics and vaccines against emerging variants NPJ systems biology and applications 10(1):138 2024 [PMID: 39604453]
  75. O'Brien G, Ganjigunta R, Dhillon PS. Wellness Influencer Responses to COVID-19 Vaccines on Social Media: A Longitudinal Observational Study Journal of medical Internet research 26:e56651 2024 [PMID: 39602782]
  76. Jin L, Zhou Y, Zhang S, Chen SJ. mRNA Vaccine Sequence and Structure Design and Optimization: Advances and Challenges The Journal of biological chemistry :108015 2024 [PMID: 39608721]
  77. Chang KW, Fang HY, Leu SW, Chen WH, Kao KC, Hu HC. Impact of COVID-19 Omicron variant on lung transplantation patients with 1-year follow-up: A single tertiary medical center experience Journal of the Formosan Medical Association = Taiwan yi zhi 2024 [PMID: 39603912]
  78. Jayadas TTP, Jeewandara C, Senadheera B, Kuruppu H, Wickramanayake R, Chathurangika PH, Senatilleke N, Warnakulasuriya N, Bary F, Wijewickrama A, Manilgama S, Gamage M, Perera N, Ogg GS, Malavige GN. Genomic surveillance and evolutionary dynamics of influenza a virus in Sri Lanka Virology journal 21(1):304 2024 [PMID: 39593174]
  79. Sun L, Zhou B, Guo Y, Huang Y, Tang Z, Wu Z, Li Y, Zhao L, Shan Y, Xu X, Jiang H. Clinical characteristics and booster vaccine effectiveness of the Omicron variant BMC infectious diseases 24(1):1351 2024 [PMID: 39593005]
  80. Middleton D, Clark L, Mosnier A, Heininger U. Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany BMC primary care 25(1):402 2024 [PMID: 39592926]
  81. Shah AU, Hemida MG. The dual actions of miRNA16a in restricting Bovine Coronavirus replication through downregulation of Furin and enhancing the host immune response Scientific reports 14(1):29308 2024 [PMID: 39592722]
  82. Masaba R, Siamba S, Hoffman HJ, Osire E, Kimani N, Kwasa M, Songane M, Denoeud-Ndam L. A Cross-Sectional Study of the Use of Antigen Rapid Diagnostic Tests for Community Identification of Severe Acute Respiratory Syndrome Coronavirus-2 in Kenya The American journal of tropical medicine and hygiene 2024 [PMID: 39591654]
  83. Castillo-Neyra R, Díaz EW, Ortiz-Cam L, Porras G, De La Puente-León M, Condori GF, Chuquista-Alcarraz O, Recuenco SE, Tamayo LD, Buttenheim AM, Paz-Soldan VA. Human-Centered Design to Respond to Public Health Crises: Maintaining Canine Rabies Vaccination during the COVID-19 Pandemic in Peru The American journal of tropical medicine and hygiene 2024 [PMID: 39591639]
  84. Jungkunz S. Asymmetric polarization by vaccination status identification during the COVID-19 pandemic PloS one 19(11):e0311962 2024 [PMID: 39591428]
  85. Suryadevara N, Kose N, Bangaru S, Binshtein E, Munt J, Martinez DR, Schäfer A, Myers L, Scobey TD, Carnahan RH, Ward AB, Baric RS, Crowe JE Jr. Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV The Journal of clinical investigation 2024 [PMID: 39589795]
  86. See LKY, Provido MT, Ng S, Yow FC, Ho XL, Lee KS, Neo HY, Ng OT, Marimuthu K, Hum AYM, Goh WY. High Dyspnea Score, a Trigger for Specialist Palliative Care Utilization-Results from a Cohort Study on the Predictors of High Opioid and Benzodiazepine Use in COVID-19 Patients Journal of palliative medicine 2024 [PMID: 39588828]
  87. Mehmood S, Naseer S, Chen DL. Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind Proceedings of the National Academy of Sciences of the United States of America 121(48):e2406034121 2024 [PMID: 39570313]
  88. Avery K, Chen X. Integration of bioprinting advances and biomechanical strategies forin vitrolung modelling Biofabrication 17(1) 2024 [PMID: 39536463]
  89. Clark JJ, Hoxie I, Adelsberg DC, Sapse IA, Andreata-Santos R, Yong JS, Amanat F, Tcheou J, Raskin A, Singh G, González-Domínguez I, Edgar JE, Bournazos S, Sun W, Carreño JM, Simon V, Ellebedy AH, Bajic G, Krammer F. Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination Cell reports 43(11):114922 2024 [PMID: 39504245]
  90. Choi YJ, Jung J, Kang M, Choi MJ, Choi WS, Seo YB, Hyun HJ, Yoon Y, Choe YJ, Cho GJ, Kim YE, Kim DW, Seong H, Nham E, Yoon JG, Noh JY, Song JY, Kim WJ, Cheong HJ. The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination Vaccine 44:126506 2024 [PMID: 39591703]
  91. Piano MGD, Russo M, Vassallo F, Buono P, Ciarambino T, Carbone C, Russo G. Post COVID-19 vaccination coverage recovery model Italian journal of pediatrics 50(1):252 2024 [PMID: 39587625]
  92. Sità L, Caserotti M, Zamparini M, Lotto L, de Girolamo G, Girardi P. Impact of COVID-19 vaccination on preventive behavior: The importance of confounder adjustment in observational studies PloS one 19(11):e0313117 2024 [PMID: 39585840]
  93. Li C, Yu J, Issa R, Wang L, Ning M, Yin S, Li J, Wu C, Chen Y. CoronaVac-induced antibodies that facilitate Fc-mediated neutrophil phagocytosis track with COVID-19 disease resolution Emerging microbes & infections :2434567 2024 [PMID: 39584817]
  94. Liu T, Wang S, Li W. [Research progress in the translation efficiency of mRNA vaccines] Sheng wu gong cheng xue bao = Chinese journal of biotechnology 40(11):3930-3950 2024 [PMID: 39584326]
  95. Xu T, Zhou YC, Liu ZY, Zhang JZ, Wu F, You D, Ge LP, Liu ZH, Sun J, Zeng X, Lai SY, Ai YR, Huang JB, Zhu L, Xu ZW. Prevalence and genetic diversity of porcine epidemic diarrhea virus in Southwest China during 2020-2022 Scientific reports 14(1):29124 2024 [PMID: 39582049]
  96. Prahlow JA. Deaths Related to New-Onset Seizures After Vaccination Academic forensic pathology :19253621241297029 2024 [PMID: 39600629]
  97. Burley SK. Protein data bank: From two epidemics to the global pandemic to mRNA vaccines and Paxlovid Current opinion in structural biology 90:102954 2024 [PMID: 39586184]
  98. Singh G, García-Bernalt Diego J, Warang P, Park SC, Chang LA, Noureddine M, Laghlali G, Bykov Y, Prellberg M, Yan V, Singh S, Pache L, Cuadrado-Castano S, Webb B, García-Sastre A, Schotsaert M. Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice Nature communications 15(1):10178 2024 [PMID: 39580470]
  99. Betow JY, Turon G, Metuge CS, Akame S, Shu VA, Ebob OT, Duran-Frigola M, Ntie-Kang F. The Chemical Space Spanned by Manually Curated Datasets of Natural and Synthetic Compounds with Activities against SARS-CoV-2 Molecular informatics :e202400293 2024 [PMID: 39578963]
  100. Lyu C, He Z, Hu X, Wang S, Qin M, Zhu L, Li Y, Yang F, Jiao Z, Zhang X, Lu G, Wang E, Hu Y, Zhai Y, Wang Y, Huang W, Wang D, Cui Y, Pang X, Liu X, Kamiya H, Ma G, Wei W. Lysosomal "TRAP": a neotype modality for clearance of viruses and variants Nature communications 15(1):10155 2024 [PMID: 39578473]

See more by clicking HERE


** Click HERE to see the latest publications in this month.